A sensor device for detecting a change fluid level within body tissue comprising a housing with bridge segments connecting at intersections arranged to circumscribe an opening. Further, antenna elements are partially seated within the housing at intersections of bridge segments, comprise a generally planar antenna mounted to a substrate material at a base of the planar antenna, and an electrical shield surrounding the substrate. Also, an outer surface of the planar antenna faces away from the substrate. The antenna elements comprise at least first and second antenna element pairs having transmitting and receiving antenna elements and a bridging segment. A high sensitivity zone is formed between the transmitting antenna and receiving antenna. The antenna element pairs are spaced to create an area of reduced sensitivity between the high sensitivity zones, and the space is set so that the sensor is insensitive to fluid changes of a predetermined volume.
|
11. A sensor for detecting a change in the level of fluid within tissue of a body, comprising:
a first antenna pair comprising a first transmitting antenna element and a first receiving antenna element, the first transmitting antenna element being spaced from and connected to the first receiving antenna element by a first bridging segment; and
at least a second antenna pair comprising a second transmitting antenna element and a second receiving antenna element, the second transmitting antenna element being spaced from and connected to the second receiving antenna element by a second bridging segment,
the first antenna pair and the second antenna pair being placed in spaced connection by a first spacing segment and a second spacing segment so that an open area is defined by the first antenna pair, the second antenna pair, the first spacing segment and the second spacing segment,
wherein the first spacing segment connects a housing section of the first transmitting antenna element to a housing section of the second transmitting antenna element and the second spacing segment connects a housing section of the first receiving antenna element to a housing section of the second receiving antenna element,
wherein the first spacing segment and the second spacing segment space the first antenna pair and the second antenna pair to create an area of reduced sensitivity between a first high sensitivity zone and a second high sensitivity zone,
wherein the space between the first antenna pair and the second antenna pair is set so that the sensor is insensitive to fluid changes of a predetermined volume within the area of reduced sensitivity.
1. A sensor device for detecting a change in the level of fluid within tissue of a body, the sensor device comprising:
a housing having a plurality of bridge segments, the bridge segments connecting at intersections and being arranged to circumscribe an opening defined by the housing; and
a plurality of antenna elements at least partially seated within the housing at intersections of the bridge segments, each of the plurality of antenna elements comprising a generally planar antenna mounted to a substrate material at a base of the planar antenna, an outer surface of the planar antenna facing away from the substrate, each of the plurality of antenna elements further comprising an electrical shield surrounding the substrate,
wherein the each of the plurality of antenna elements comprises at least a first antenna element pair and a second antenna element pair, the first antenna element pair comprising a first transmitting antenna element, a first receiving antenna element, and a first bridging segment, the second antenna element pair comprising a second transmitting antenna element, a second receiving antenna element and a second bridging segment,
wherein a first high sensitivity zone is formed between the first transmitting antenna element and the first receiving antenna element and a second high sensitivity zone is formed between the second transmitting antenna element and the second receiving antenna element
wherein the first antenna element pair and the second antenna element pair are spaced from each other to create an area of reduced sensitivity between the first high sensitivity zone and the second high sensitivity zone,
wherein the space between the first antenna element pair and the second antenna element pair is set so that the sensor is insensitive to fluid changes of a predetermined volume within the area of reduced sensitivity.
2. The sensor device of
3. The sensor device of
4. The sensor device of
5. The sensor device of
6. The sensor device of
an adhesive portion defining a cutout region generally coextensive with the opening of the housing, the adhesive portion having one side thereof coated with a first adhesive adapted to removably attach to the tissue and an opposite side thereof coated with a second adhesive adapted to attach to a bottom surface of the housing.
7. The sensor device of
8. The sensor device of
9. The sensor device of
10. The sensor device of
12. The sensor of
13. The sensor device of
14. The sensor device of
15. The sensor device of
16. The sensor device of
17. The sensor device of
18. The sensor of
an adhesive portion defining a cutout region generally coextensive with the open area, the adhesive portion having one side thereof coated with a first adhesive adapted to removably attach to the tissue and an opposite side thereof coated with a second adhesive adapted to attach to the sensor.
19. The sensor of
|
This application claims benefit of U.S. Provisional Patent Application Ser. No. 60/514,355, filed Oct. 24, 2003, the disclosure of which is incorporated herein by reference.
The present invention relates generally to the detection of fluid and/or other material in tissue, and especially, to systems, methods and/or devices for detecting changes in the level of fluid in tissue. In certain embodiments, the systems, methods and/or devices of the present invention detect if fluid level has increased or, has otherwise become abnormal.
The following information is provided to assist the reader to understand the invention disclosed below and the environment in which it will typically be used. The terms used herein are not intended to be limited to any particular narrow interpretation unless clearly stated otherwise in this document. References set forth herein may facilitate understanding of the present invention or the background of the present invention. Inclusion of a reference herein, however, is not intended to and does not constitute an admission that the reference is available as prior art with respect to the present invention
Changed, elevated or abnormal fluid levels in living tissue can result from a number of physiological conditions. For example, edema is an abnormal accumulation of watery fluid in the intercellular spaces of connective tissue. Edematous tissues are swollen and, when punctured, secrete a thin incoagulable fluid. Edema is most frequently a symptom of disease rather than a disease in itself, and it may have a number of causes, most of which can be traced back to gross variations in the physiological mechanisms that normally maintain a constant water balance in the cells, tissues, and blood. Among the causes may be diseases of the kidneys, heart, veins, or lymphatic system; malnutrition; or allergic reactions.
Moreover, bleeding (hemorrhage) can cause blood to collect and clot (hematoma). Hematomas can, for example,)occur beneath the outermost of three membranes that cover the brain (meninges) as a result of a head injury. There are two types of cranial subdural hematomas. An acute subdural hematoma occurs soon after a severe head injury. A chronic subdural hematoma is a complication that may develop weeks after a head injury. Such a head injury may have been so minor that the patient does not remember it. An epidural hematoma is a traumatic accumulation of blood between the inner table of the skull and the stripped-off dural membrane. The inciting event often is a focused blow to the head. It is often difficult to detect hematomas, particularly when the hematoma occurs well after the time of an injury.
In addition to accumulation of body fluids, elevated fluid levels in tissue can arise as a result of introduction of a fluid into the body, for example, during an injection procedure. In that regard, in many medical diagnostic and therapeutic procedures, a physician or other person injects fluid into a patient's blood vessels. Moreover, in recent years, a number of injector-actuated syringes and powered injectors for pressurized injection of contrast medium in procedures such as angiography, computed tomography, ultrasound and NMR/MRI have been developed.
Extravasation or infiltration is the accidental infusion or leakage of an injection fluid such as a contrast medium or a therapeutic agent into tissue surrounding a blood vessel rather than into the blood vessel itself. Extravasation can be caused, for example, by rupture or dissection of fragile vasculature, valve disease, inappropriate needle placement, or patient movement resulting in the infusing needle being pulled from the intended vessel or causing the needle to be pushed through the wall of the vessel. High injection pressures and/or rates of some modern procedures can increase the risk of extravasation. In computed tomography, for example, contrast injection flow rates can be in the range of 0.1 to 10 ml/s.
Extravasation can cause serious injury to patients. In that regard, certain injection fluids such as contrast media or chemotherapy drugs can be toxic to tissue. It is, therefore, very important when performing fluid injections to detect extravasation as soon as possible and discontinue the injection upon detection.
Several extravasation detection techniques are known in the art. Two simple and very useful techniques for detecting extravasation are palpation of the patient in the vicinity of the injection site and simple visual observation of the vicinity of the injection site by a trained health care provider. In the palpation technique, the health care provider manually senses swelling of tissue near the injection site resulting from extravasation. By visual observation, it is also sometimes possible to observe directly any swelling of the skin in the vicinity of an injection site resulting from extravasation.
In addition to palpation and observation, there are a number of automated methods of detecting extravasation that may include automatic triggering of an alarm condition upon detection. Unfortunately, each of these automated methods of detecting extravasation is limited by significant drawbacks.
In that regard, several plethysmographic detection techniques are available. For example, mercury strain gauge plethysmographs measure the volume change resulting from venous blood flow in a cross sectional area of a limb of a patient. Air cuff or pulse volume recorder plethysmographs measure the changes in pressure within a recording cuff. Such plethysmographs can be cumbersome to operate and/or insensitive to small changes in volume.
Impedance plethysmographs use low-frequency electromagnetic energy transmitted via galvanic contact with the skin to measure changes in the electrical impedance in a defined tissue volume of a limb. Detection of extravasation via impedance changes is disclosed, for example, in U.S. Pat. Nos. 5,964,703 and 5,947,910. In this method, an impedance change of a certain level relative to a baseline measurement in the vicinity of the injection site is interpreted as being an extravasation. A change in impedance occurs during extravasation because injection fluid in the tissue of the patient changes both the volume and the electrical impedance properties of the tissue. Use of electrodes in impedance plethysmographs can, however, result in instabilities. For example, maintaining suitable electrical (ohmic or galvanic) contact between the electrodes of impedance plethysmographs and the skin of the patient is often very difficult.
Photo-plethysmographs measure the optical scattering properties of capillary blood to detect the presence of extravasated fluids in tissue. An example of a photo-plethysmograph is described in U.S. Pat. No. 4,877,034. Because light is heavily absorbed in tissue, however, the sensitivity of photo-plethysmographs is generally limited to the top ¼ inch of tissue. Many extravasations, however, occur deeper than ¼ inch. Moreover, the injection medium may flow into interstitial spaces remote from the photoplethysmograph sensors and go undetected.
A number of extravasation detection devices attempt to measure temperature differences to determine if an extravasation has occurred. For example, U.S. Pat. No. 4,647,281 discloses subcutaneous temperature sensing of extravasation to trigger an alarm. In this method of extravasation detection, an antenna and a microwave radiometer instantaneously measure the temperature of the subcutaneous tissue at the site where fluid is injected by measuring microwave radiation emitted naturally from the body. An algorithm periodically determines the temperature difference between tissue and injected fluid, and compares the difference to a fixed threshold. An alarm processor uses the comparison to determine an alarm condition.
In addition, U.S. Pat. No. 5,334,141 discloses a microwave extravasation detection system employing a reusable microwave antenna and a disposable attachment element for releasably securing the microwave antenna to a patient's skin over an injection site. The attachment element holds the antenna in intimate contact with the patient's skin to optimize microwave transfer therebetween, while shielding the antenna from environmental noise signals. U.S. Pat. No. 5,954,668 also discloses use of a microwave antenna to sense temperature of tissue to detect extravasation. Although measurement of temperature changes and emissivity using microwave energy can result in instantaneous detection, temperature differences are often too small for practical measurement.
In addition to microwave radiometry for the detection of extravasation as described above, radiometry has also been proposed for the detection of pulmonary edema as described in U.S. Pat. No. 4,488,559. U.S. Pat. No. 4,240,445 discloses detection of pulmonary edema via transmitting electromagnetic energy through a transmission line coupled to tissue. U.S. Pat. No. 4,690,149 discloses detection of brain edema via impedance changes detected by a sensor. A proposed method of detection of brain edema is also disclosed in U.S. Pat. No. 6,233,479, in which a measured signal from a microwave antenna is compared to a stored characteristic edema signal.
Microwave energy has also been used for the detection of tumors in living tissue as described in U.S. Pat. No. 6,061,589. Unlike the passive measurements in microwave radiometry, U.S. Pat. No. 6,061,589 disclosed transmission of electromagnetic energy into the body (breast tissue) using a microwave antenna in and a resultant signal is measured. In that regard, U.S. Pat. No. 6,061,589 describes a microwave antenna to detect incipient tumors in accordance with differences in relative dielectric characteristics. Electromagnetic energy in the microwave frequency range is, applied to a discrete volume in the tissue and scattered signal returns are collected. The irradiated location is shifted or changed in a predetermined scanning pattern. The returned signals are processed to detect anomalies indicative of the present of a tumor.
Microwave energy has also been used as in non-invasive tomographic spectroscopy imaging. See U.S. Pat. Nos. 6,332,087 and 6,026,173. Microwave energy has further been used to measure the fat content in nonliving organic tissue. For example, M. Kent, “Hand Held Fat/Water Determination”, (1993), available at www.distell.com/products/papers/pap- er2.htm, discloses a microstrip sensor for such a determination. In general, the fat content of pelagic and other fatty species of fish is proportion to water content. The dielectric properties of the fish depend on the water content. In the device of Kent, changes in transmission properties of the fish were calibrated against water content.
It is desirable to develop improved devices, systems and methods for detecting changes in fluid levels in tissue, and particularly, for detecting elevated or otherwise abnormal levels of fluids in living tissue (for example, as a result of edema, hematoma or extravasation). The objectives and advantages of the invention herein presented will become fully apparent to persons skilled in the relevant art from a reading of the detailed description section of this document, and will become particularly apparent when the detailed description is considered along with the drawings and claims presented herein.
The objectives and advantages of the invention are attained by the various embodiments and related aspects of the invention summarized below.
In one aspect, the present invention provides a sensor device for detecting a change in the level of fluid within tissue of a body including: a housing having a plurality of bridge segments, the bridge segments connecting at intersections and being arranged to circumscribe an opening defined by the housing; and a plurality of antenna elements at least partially seated within the housing at intersections of the bridge segments. Each of the plurality of antenna elements includes a generally planar antenna mounted to a substrate material at a base of the planar antenna. An outer surface of the planar antenna faces away from the substrate. Each of the plurality of antenna elements further includes an electrical shield surrounding the substrate.
In one embodiment, the sensor device further includes an RF cable assembly for each of the antenna elements. Each of the RF cable assemblies includes at one end thereof a connector. At the other end thereof, the RF cable assembly is electrically connected to the antenna element corresponding thereto. The sensor device can additionally or alternatively include at least one flexible circuit board assembly for transmission of energy to and from the antenna elements. The flexible circuit board can include at least one splitter such that electromagnetic energy can be transmitted to at least two of the plurality of antenna elements using a single transmission trace within the flexible circuit board. The flexible circuit board can include at least one combiner such that electromagnetic energy can be received from at least two of the plurality of antenna elements and carried by a single transmission trace within the flexible circuit board.
The sensor device can further include an attachment mechanism to operably attach the sensor device to the tissue of the body. The attachment mechanism can include an adhesive portion defining a cutout region generally coextensive with the opening of the housing. The adhesive portion has one side thereof coated with a first adhesive adapted to removably attach to the tissue and an opposite side thereof coated with a second adhesive adapted to attach to a bottom surface of the housing. The attachment mechanism can further include a release band affixed to a perimeter of the adhesive portion. In one embodiment, the first adhesive is adapted to facilitate removal of the attachment mechanism from the patient. For example, the first adhesive can provide less adhesion than the second adhesive.
In one embodiment, each of the plurality of antenna elements of the sensor device includes at least a first antenna element pair and a second antenna element pair. The first antenna element pair includes a first transmitting antenna element and a first receiving antenna element. Likewise, the second antenna element pair includes a second transmitting antenna element and a second receiving antenna element.
The first antenna element pair and the second antenna element pair can be spaced from each other to create an area of reduced sensitivity between the first antenna element pair and the second antenna element pair. The space between the first antenna element pair and the second antenna element pair can be set so that the sensor is insensitive to fluid changes of a predetermined volume within the area of reduces sensitivity. A first area of higher sensitivity can be defined by the area between the first transmitting antenna element and the first receiving antenna element. A second area of higher sensitivity can be defined by the area between the second transmitting antenna element and the second receiving antenna element.
In another aspect, the present invention provides a sensor for detecting a change in the level of fluid within tissue of a body including a first antenna pair including a first transmitting antenna and a first receiving antenna. The first transmitting antenna is spaced from and connected to the first receiving antenna by a first bridging segment.
The sensor further includes at least a second antenna pair including a second transmitting antenna and a second receiving antenna. The second transmitting antenna is spaced from and connected to the second receiving antenna by a second bridging segment. The first antenna pair and the second antenna pair are placed in spaced connection by a first spacing segment and a second spacing segment so that an open area is defined by the first antenna pair, the second antenna pair, the first spacing segment and the second spacing segment.
Each antenna element can be surrounded by a housing section. Each of the antenna elements can include a substrate mounted within the housing section and a generally planar antenna element mounted to the substrate.
In one embodiment, the first bridging segment connects the housing section of the first transmitting antenna to the housing section of the first receiving antenna, and the second bridging segment connects the housing section of the second transmitting antenna to the housing section of the second receiving antenna. The first spacing segment can connect the housing section of the first transmitting antenna to the housing section of the second transmitting antenna, and the second spacing segment can connect the housing section of the first receiving antenna to the housing section of the second receiving antenna.
The first spacing segment and the second spacing segment can space the first antenna pair and the second antenna pair to create an area of reduced sensitivity between the first antenna pair and the second antenna pair.
In another aspect, the present invention provides a system for wirelessly communicating a change in the level of fluid within tissue of a body. The system includes: a sensor device for detecting a change in the level of fluid within the tissue; a transmitter in operative connection with the sensor device for receiving therefrom a signal indicative of the change in the level of fluid within the tissue and for transmitting a wireless signal indicative of the change in level of fluid; and a remote receiver for receiving the wireless signal transmitted by the transmitter. The remote receiver can include an indicator to provide an alert of a state determined from the received wireless signal.
In one embodiment, the sensor device can include a housing having a plurality of bridge segments, wherein the bridge segments connect at intersections and are arranged to circumscribe an opening defined by the housing. The sensor device further includes a plurality of antenna elements at least partially seated within the housing at intersections of the bridge segments. Each of the plurality of antenna elements can include a generally planar antenna mounted to a substrate material at a base of the planar antenna. An outer surface of the planar antenna faces away from the substrate. Each of the plurality of antenna elements further includes an electrical shield surrounding the substrate.
In another embodiment, the sensor device includes a first antenna pair including a first transmitting antenna and a first receiving antenna. The first transmitting antenna is spaced from and connected to the first receiving antenna by a first bridging segment. The sensor device further includes at least a second antenna pair including a second transmitting antenna and a second receiving antenna The second transmitting antenna is spaced from and connected to the second receiving antenna by a second bridging segment. The first antenna pair and the second antenna pair can be placed in spaced connection by a first spacing segment and a second spacing segment so that an open area is defined by the first antenna pair, the second antenna pair, the first spacing segment and the second spacing segment.
In a further embodiment, the sensor device includes a first antenna pair including a first transmitting antenna and a first receiving antenna The first transmitting antenna is spaced from and connected to the first receiving antenna by a first bridging segment. The sensor device further includes at least a second antenna pair including a second transmitting antenna and a second receiving antenna. The second transmitting antenna is spaced from and connected to the second receiving antenna by a second bridging segment. The first antenna pair is spaced from the second antenna pair by at least one spacing segment so that an area of reduced sensitivity is created in the space between the first antenna pair and the second antenna pair.
In another aspect, the present invention provides an attachment mechanism for use in attaching a sensing device to the skin of a patient including: an adhesive portion having a first side coated with a first adhesive adapted to removably attach to the skin and a second side, opposite the first side and coated with a second adhesive adapted to attach to the sensing device; and a release band affixed to a perimeter of the adhesive portion to facilitate removal of the attachment mechanism from attachment to the skin.
The adhesive portion can, for example, define a cutout region generally coextensive with an opening defined by the sensing device. The first adhesive can be adapted to facilitate removal of the attachment mechanism from attachment to the skin. The first adhesive can, for example, provide less adhesion than said second adhesive.
In a further aspect, the present invention provides a method of sensing a change in fluid level in living tissue in a patient including: placing a first antenna pair in contact with the patient, the first antenna pair including a first transmitting antenna and a first receiving antenna; and placing a second antenna pair in contact with the patient, the second antenna pair including a second transmitting antenna and a second receiving antenna The first antenna pair and the second antenna pair are spaced when in contact with the patient to create an area of reduced sensitivity between the first antenna pair and the second antenna pair.
The space between the first antenna pair and the second antenna pair can be set so that a sensor device including the first antenna pair and the second antenna pair is insensitive to fluid changes of a predetermined volume within the area of reduced sensitivity. A first area of higher sensitivity can be defined by the area between the first transmitting antenna and the first receiving antenna, and a second area of higher sensitivity can be defined by the area between the second transmitting antenna and the second receiving antenna.
In still a further aspect, the present invention provides a method of sensing an extravasation of fluid being injected into living tissue of a patient including: placing a first antenna pair in contact with the patient, the first antenna pair including a first transmitting antenna and a first receiving antenna; placing a second antenna pair in contact with the patient, the second antenna pair including a second transmitting antenna and a second receiving antenna, transmitting electromagnetic energy in the frequency range of approximately 300 MHz to approximately 30 GHz via the first transmitting antenna and the second transmitting antenna; measuring resultant signals from the first receiving antenna and the second receiving antenna; and comparing the signals to a reference to determine if fluid level in the tissue has changed during the period of time. The first antenna pair and the second antenna pair are spaced when in contact with the patient to create an area of reduced sensitivity between the first antenna pair and the second antenna pair. The sensor device can, for example, include a housing that maintains the first antenna pair and the second antenna pair in spaced connection.
The space between the first antenna pair and the second antenna pair can be set so that a sensor device including the first antenna pair and the second antenna pair is insensitive to extravasations of a predetermined volume within the area of reduced sensitivity. A first area of higher sensitivity can be defined by the area between the first transmitting antenna and the first receiving antenna, and a second area of higher sensitivity can be defined by the area between the second transmitting antenna and the second receiving antenna.
In one embodiment, the frequency is in the range of approximately 1 GHz to approximately 10 GHz. In another embodiment, the frequency is in the range of approximately 3 GHz to approximately 5 GHz.
The invention, and particularly its presently preferred and alternative embodiments and related aspects, will be better understood by reference to the detailed disclosure below and to the accompanying drawings, in which:
While the sensors, systems and methods of the present invention are generally applicable to the sensing any fluid within body tissue (whether a body fluid or an introduced fluid), the present invention is primarily described herein with reference to the representative example of extravasation of a fluid intended to be injected into a vascular structure. One skilled in the art will appreciate, however, that elevated, abnormal or changing levels of generally any fluid can be detected using the sensors, systems and methods of the present invention. Detection of body fluids in the present invention includes, but is not limited to, the detection of fluid changes as a result of edema, hematoma, ruptured bowel and colostomy tubing leakage into the peritoneal cavity. Introduced or foreign fluid detectible in the present invention include fluid introduced via generally any technique known in the medical arts including, but not limited to, injection, infusion and IV drip. As described above, changes in complex permittivity and permeability as a result of changing fluid levels in tissue are detected by application of electromagnetic energy to the tissue and detection of a resultant signal.
Complex permittivity and permeability govern how an electromagnetic wave will propagate through a substance. Complex permittivity typically has the greatest effect since it varies significantly between tissue types and fluids of interest. The complex permeability of various tissues and many fluids of interest is approximately that of a vacuum, reducing the effect of this parameter. Some fluids, however, such as MRI contrast agents may have an appreciable complex permeability difference from tissue.
Although blood contains small amounts of iron, the permeability value for any significant volume of blood is typically insignificant. Complex permittivity is generally expressed as:
∈*=∈′−j∈″
wherein ∈′ is the real component of the complex value and is known as the dielectric constant or sometimes simply referred to as the “permittivity.” The term ∈″ is the imaginary component of the complex value and is often referred to as the “loss factor.” The ratio of (∈″/∈′) is known as the “loss tangent.” The complex permittivity (and sometimes permeability) of certain substances differ from the body tissue at certain frequencies. In the present invention, such differences in permittivity and/or permeability are used for the detection and level monitoring of certain fluids and substances in biological tissue.
Published U.S. Patent Application Publication Nos. 2003/0036674 and 2003/0036713, assigned to the assignee of the present invention, the disclosures of which are incorporated herein by reference, disclose transmitting and receive antenna elements, sensing methods and processing algorithms suitable for use in the present invention. The studies of sensors incorporating such antenna elements have shown that electromagnetic energy having, for example, a frequency in the range of approximately 300 MHz to approximately 30 GHz (and, more preferably, in the range of approximately 1 GHz to approximately 10 GHz, and, even more preferably, in the range of approximately 3 GHz to approximately 5 GHz) provides good penetration into tissue. In general, such electromagnetic energy is launched into the subcutaneous tissue and a resultant signal is measured. Electromagnetic energy in the frequency range set forth above has been found to transmit through the skin and to transmit or propagate well within, for example, fat. Good transmission through the fat layer is beneficial for detection of extravasation as many extravasations occur in the fat layer. The sensitivity to extravasation of the systems, devices and methods of the present invention is thus increased as compared, for example, to impedance plethysmography.
The housing 20 can, for example, be fabricated from a base material, such as urethane and/or silicone material. A ferromagnetic and/or other material suitable to absorb leakage of electromagnetic energy can be mixed into the base material. A carbonyl iron powder, such as the EW grade carbonyl iron powder produced by the BASF Corporation, of Mount Olive, N.J., is suitable for this purpose. The ferromagnetic powder is mixed into the housing base material at least around the antenna elements and cables. A ferromagnetic material with appreciable permeability (e.g., >1), such as the EW grade carbonyl iron powder, provides a mixture that creates a flexible housing capable of absorbing stray leakage of electromagnetic energy. If not effectively addressed, such leakage could potentially cause artifacts to be induced within the signals conveyed from the antenna elements 30 as a result of, for example, palpation of the skin in the area of the extravasation sensor 10 or as a result of other movement of the sensor 10. In addition to motion and palpation artifacts, such leakage could also decrease the sensitivity of the sensor 10 to the presence of subcutaneous fluid. It is apparent that one can also mix the ferromagnetic material into a different base material (for example, a base material that will form a more rigid housing).
As illustrated, for example, in
Housing 20 also includes segments 30 and 30a that bridge the gap between seatings 40 (positioned at intersections 50 between connected segments 30 and 30a) in which antenna elements 60a-d are seated. Bridge segments 30 and 30a are, for example, low in profile to provide an operator access through opening 24 to the site of interest for the purpose of palpation. Nurses or technologists often position their hand in such a manner that low-profile bridge segments 30 and 30a (particularly those bridge segments 30a on the sides of sensor 10) allow improved ability to palpate the site of interest to check for extravasation. As best shown in
Similar to the antenna element described in Published U.S. Patent Application Nos. 2003/0036674 and 2003/0036713, antenna elements 60a-d (each of which is generally identical in structure), in several embodiments of the present invention, include an active antenna or resonant structure 62 surrounded by a substrate 64 such as a ceramic material (for example, MgCaTiO2). Resonant structures 62 are, for example, adapted to transmit and receive electromagnetic energy in the frequency ranges set forth above. The substrate material can, for example, have a moderate to high dielectric constant (for example, in the range of approximately 5 to approximately 100 or in the range of approximately 50 to approximately 80) or high permittivity and low loss. To reduce the size of the antenna structure, several embodiments used in the studies of the present invention used a ceramic material in the range of 5-15, thereby reducing manufacturing costs The impedance of substrate 64 is preferably similar to that of the surface of the tissue to be studied.
Unlike several of the embodiments of the antenna elements of U.S. Patent Application Nos. 2003/0036674 and 2003/0036713, antenna elements 60a-d of the present invention did not include a superstrate material. In U.S. Patent Application Publication Nos. 2003/0036674 and 2003/0036713, the antenna elements such as shown in
Microstrip antennae 60a through 60d used in several studies of the present invention were fabricated from a ceramic laminate material coated with thin layers of copper on the front and back thereof. Such a material is, for example, available from Rogers Corporation of Chandler, Ariz. under the product name RT/duroid® 6010LM. Such microwave laminates are ceramic-PTFE composites designed for electronic and microwave circuit applications requiring a relatively high dielectric constant.
RT/duroid 6010LM laminate has a dielectric constant of approximately 10.2. The laminate was approximately 2.5 mm thick and was supplied with both sides thereof clad with ¼ to 2 oz./ft.2 (8 to 70 μm) electrodeposited copper foil. In fabricating antennae (or microstrip antennae) 60a-d of the present invention, some of the copper material was etched from the top of the laminate to form generally planar antenna active element or resonant structure 62, thereby forming a margin between the outer edge of resonant structure 62 and the outer edge of substrate 64. The copper on the bottom side of the laminate formed ground plane 66 of antenna 62a-d. Side shielding 68 of a conductive material can be provided to, for example, improve tissue coupling and prevent stray energy.
Side shielding 68 and rearward, ground plane 66 form an electrically conductive cavity. Resonant structure 62 and the cavity can resonate together in the frequency range of interest. Such resonance matching can improve efficiency by, for example, increasing power output relative to power input for transmission, and increasing power received relative to power available for reception. Each antenna element 60a through 60d can also include a conductive front lip 67 on the surface of the ceramic material to provide additional shielding. Coupled with the protection provided by the side shielding 68, forward conductive lip 67 for each antenna elements 60a-d serves to further decrease the leakage of stray electromagnetic energy. In one embodiment, conductive lip 67 was fabricated from a conductive material such as copper having a thickness of approximately 0.010 inches.
Although square antennae or resonant structures 62 were used in the studies of the present invention, it is clear to one skilled in the art that many alternative antenna element or resonant structure geometries (for example, circular or rectangular) can be used in the antennae of the present invention.
In the embodiment of
Using sensing algorithms and thresholds as disclosed in Published U.S. Patent Application Nos. 2003/0036674 and 2003/0036713, small volumes of fluid (for example, volumes no greater than 5 cc or no greater than 3 cc) can accumulate within the overall sensing region while not crossing the alarm threshold. Further, higher threshold values can be set and remain effective at desired levels (that is, clinically significant levels). Moreover, by creation of reduced sensitivity zone 84 the volume at which the overall sensing region begins to become saturated (i.e., at which fluid has filled the overall sensing region and the sensor's the signal stops changing) is increased to a larger volume by creation of reduced sensitivity zone 84.
As described above, reduced sensitivity zone 84 allows small, clinically insignificant, extravasation (blood and/or contrast agent) volumes to accumulate while significantly reducing the probability of a false positive alarm. Indeed, in several clinical studies of the present invention, false positive alarms were maintained below 0.1% while a positive extravasation detection rate in excess of 95% was achieved.
As illustrated for example in
In addition to maintaining a predetermined, desired spacing between the antenna elements of each antenna element pair and a predetermined, desired spacing between the antenna element pairs, housing 20 also maintains a desired relative orientation between the antenna elements of each antenna element pair and between the antenna element pairs. Also, housing 20 assists in assuring that each of antenna elements 60a-d is generally coplanar when sensor device 10 is in operative connection with a patient's skin.
A further advantage of the use of flex circuit board in connection with an energy transmission system of the sensors of the present invention is that a low-profile connection to the antennas elements can be achieved. Use of coaxial cables which are soldered to the antennas elements of the present invention can require a sizeable bending radius, creating a higher profile connection. RF flex circuit includes an RF vertical transition including a center signal via surrounded by ground/reference vias completing a coaxial structure to transmit/receive microwave energy to and from the antennas elements. The antenna elements can, for example, be wave soldered in an automated process directly to the thin RF flex circuit without use of additional connectors or cables, achieving a low-profile connection.
By using thin dielectric layers in the flex circuit boards of the present invention and designing appropriate signal traces in the signal plane, small changes in the gain and phase characteristics during, for example, bending and twisting of the RF flex circuit were achieved. These results can reduce effects, if any, of motion artifact during sensor use.
As illustrated in
As illustrated, for example, in
In several studies of the attachment mechanisms of the present invention, 3M Medical Double Coated Tape #1512 available from 3M of Saint Paul, Minn. was used. This tape is fabricated from a hypoallergenic polyethylene material. Whatever double-sided adhesive tape or film is used, the double-sided adhesive tape preferably maintains sufficient contact with the skin and (upon proper use) provides resistance to wrinkling and formation of air pockets upon placement. The double-sided adhesive tape material preferably has a low electromagnetic loss factor (that is, in the sensor's operating frequency range). Such properties allow the electromagnetic energy (for example, microwaves) to penetrate the adhesive tape effectively. Most adhesive tapes possess these characteristics. Tapes that contain metallic particles or other conductive materials, however, may not be suitable for use in the attachment mechanisms of the present invention. The tape can, however, contain, for example, a material such as a ceramic material that yields a thin structure with low electromagnetic loss and an impedance that matches the surface tissue. This embodiment can provide better coupling of the microwave energy between the antennas and the tissue to increase detection sensitivity while decreasing leaked energy and thereby decreasing any palpation/motion artifact.
As an alternative to the steps described in connection with
As shown in
Extravasation sensor 450 and other extravasation sensors of the present invention can also be equipped with one or more user interfaces or indicator.
An indicator device such as indicator light 480′ can alternatively or additionally be mounted to or otherwise integrated into a remote display or controller unit for the injector system, as, for example, illustrated in
Although the various embodiments and related aspects of the invention herein described and illustrated are presented primarily in the context of CT imaging procedures, one skilled in the art understands that the invention may also be applied or adapted to other types of applications such as positron emission tomography (PET), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA) and ultrasound procedures as well as a wide variety of therapeutic and other procedures.
The presently preferred embodiment(s) for carrying out the invention have been set forth in detail according to the Patent Act. Persons of ordinary skill in the art to which this invention pertains may nevertheless recognize alternative ways of practicing the invention without departing from the concepts and embodiments disclosed herein.
Harpham, R. Reade, Bouton, Chad E., Held, Jeffrey R., Ruggeri, Felicia R.
Patent | Priority | Assignee | Title |
10052064, | Apr 04 2013 | Thermal Technologies, Inc. | Edema monitor |
10136833, | Jul 21 2010 | ZOLL MEDICAL ISRAEL, LTD. | Implantable radio-frequency sensor |
10219741, | Feb 27 2012 | HOWMEDICA OSTEONICS CORP | Muscular-skeletal joint stability detection and method therefor |
10335055, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | Kinetic assessment and alignment of the muscular-skeletal system and method therefor |
10548485, | Jan 12 2015 | ZOLL MEDICAL ISRAEL LTD | Systems, apparatuses and methods for radio frequency-based attachment sensing |
10588599, | May 27 2008 | ZOLL MEDICAL ISRAEL LTD | Methods and systems for determining fluid content of tissue |
10660609, | Dec 01 2009 | ZOLL MEDICAL ISRAEL LTD. | Methods and systems for determining fluid content of tissue |
10663411, | Mar 21 2014 | Battelle Memorial Institute | Liquid scanning system and method for IV drug verification and identification |
10680324, | Oct 29 2013 | ZOLL MEDICAL ISRAEL LTD | Antenna systems and devices and methods of manufacture thereof |
10722136, | Sep 02 2011 | Battelle Memorial Institute | Wireless and power-source-free extravasation and infiltration detection sensor |
10724968, | Mar 21 2014 | Battelle Memorial Institute | System and method for solution constituent and concentration identification |
10746716, | May 31 2019 | Battelle Memorial Institute | System and method for solution constituent and concentration identification |
10842432, | Sep 14 2017 | HOWMEDICA OSTEONICS CORP | Medial-lateral insert sensing system with common module and method therefor |
10893955, | Sep 14 2017 | HOWMEDICA OSTEONICS CORP | Non-symmetrical insert sensing system and method therefor |
10987017, | Sep 02 2011 | Battelle Memorial Institute | Distributed extravasation detecton system |
11013420, | Feb 05 2014 | ZOLL MEDICAL ISRAEL LTD | Systems, apparatuses and methods for determining blood pressure |
11020002, | Aug 10 2017 | ZOLL MEDICAL ISRAEL LTD | Systems, devices and methods for physiological monitoring of patients |
11108153, | Oct 29 2013 | ZOLL MEDICAL ISRAEL LTD | Antenna systems and devices and methods of manufacture thereof |
11109777, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | Kinetic assessment and alignment of the muscular-skeletal system and method therefor |
11234608, | Sep 02 2011 | Battelle Memorial Institute | Extravasation and infiltration detection device with fluid guide provided on a substrate of the detection device to adjust fluid rate based on detection signal |
11241158, | Jan 12 2015 | ZOLL MEDICAL ISRAEL LTD. | Systems, apparatuses and methods for radio frequency-based attachment sensing |
11259715, | Sep 08 2014 | ZOLL MEDICAL ISRAEL LTD | Monitoring and diagnostics systems and methods |
11471127, | Dec 01 2009 | ZOLL MEDICAL ISRAEL LTD. | Methods and systems for determining fluid content of tissue |
11534316, | Sep 14 2017 | Orthosensor Inc. | Insert sensing system with medial-lateral shims and method therefor |
11539125, | Oct 29 2013 | ZOLL MEDICAL ISRAEL LTD. | Antenna systems and devices, and methods of manufacture thereof |
11793424, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | Kinetic assessment and alignment of the muscular-skeletal system and method therefor |
11812978, | Oct 15 2019 | HOWMEDICA OSTEONICS CORP | Knee balancing system using patient specific instruments |
11872012, | Aug 10 2017 | ZOLL MEDICAL ISRAEL LTD. | Systems, devices and methods for physiological monitoring of patients |
11883136, | Feb 05 2014 | ZOLL MEDICAL ISRAEL LTD. | Systems, apparatuses and methods for determining blood pressure |
11883143, | Sep 02 2011 | Battelle Memorial Institute | Wireless and power-source-free extravasation and infiltration detection sensor circuitry provided on a substrate with signal splitter |
11883144, | Sep 02 2011 | Battelle Memorial Institute | Integrated extravasation and infiltration detection device on a RF isolated flexible substrate with fluid guide to detect fluid changes via signal comparison |
11896352, | Apr 30 2020 | Bayer HealthCare LLC | System, device and method for safeguarding the wellbeing of patients for fluid injection |
11986281, | Sep 02 2011 | Battelle Memorial Institute | Distributed extravasation detection system for fluid change and to control the fluids levels in a body via wireless interface based on rate of activation |
12064284, | Dec 01 2009 | ZOLL MEDICAL ISRAEL LTD. | Methods and systems for determining fluid content of tissue |
8989837, | Dec 01 2009 | ZOLL MEDICAL ISRAEL LTD | Methods and systems for determining fluid content of tissue |
9161717, | Sep 23 2011 | HOWMEDICA OSTEONICS CORP | Orthopedic insert measuring system having a sealed cavity |
9220420, | Jul 21 2010 | ZOLL MEDICAL ISRAEL LTD | Implantable dielectrometer |
9226694, | Jun 30 2009 | HOWMEDICA OSTEONICS CORP | Small form factor medical sensor structure and method therefor |
9259172, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | Method of providing feedback to an orthopedic alignment system |
9259179, | Feb 27 2012 | HOWMEDICA OSTEONICS CORP | Prosthetic knee joint measurement system including energy harvesting and method therefor |
9265438, | Dec 01 2009 | ZOLL MEDICAL ISRAEL LTD | Locating features in the heart using radio frequency imaging |
9265447, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | System for surgical information and feedback display |
9271675, | Feb 27 2012 | HOWMEDICA OSTEONICS CORP | Muscular-skeletal joint stability detection and method therefor |
9289163, | Jun 30 2009 | HOWMEDICA OSTEONICS CORP | Prosthetic component for monitoring synovial fluid and method |
9289550, | Feb 06 2001 | Bayer HealthCare LLC | Apparatus and method for detecting fluid extravasation |
9326686, | Mar 12 2012 | ivWatch, LLC | System and method for mitigating the effects of tissue blood volume changes to aid in diagnosing infiltration or extravasation in animalia tissue |
9339212, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | Bone cutting system for alignment relative to a mechanical axis |
9345449, | Jun 30 2009 | HOWMEDICA OSTEONICS CORP | Prosthetic component for monitoring joint health |
9345492, | Jun 30 2009 | HOWMEDICA OSTEONICS CORP | Shielded capacitor sensor system for medical applications and method |
9357964, | Jun 30 2009 | HOWMEDICA OSTEONICS CORP | Hermetically sealed prosthetic component and method therefor |
9358136, | Jun 30 2009 | HOWMEDICA OSTEONICS CORP | Shielded capacitor sensor system for medical applications and method |
9402583, | Jun 30 2009 | HOWMEDICA OSTEONICS CORP | Orthopedic screw for measuring a parameter of the muscular-skeletal system |
9408557, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | System and method to change a contact point of the muscular-skeletal system |
9414940, | Sep 23 2011 | HOWMEDICA OSTEONICS CORP | Sensored head for a measurement tool for the muscular-skeletal system |
9456769, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | Method to measure medial-lateral offset relative to a mechanical axis |
9462964, | Sep 23 2011 | HOWMEDICA OSTEONICS CORP | Small form factor muscular-skeletal parameter measurement system |
9492115, | Jun 30 2009 | HOWMEDICA OSTEONICS CORP | Sensored prosthetic component and method |
9492116, | Jun 30 2009 | HOWMEDICA OSTEONICS CORP | Prosthetic knee joint measurement system including energy harvesting and method therefor |
9492238, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | System and method for measuring muscular-skeletal alignment to a mechanical axis |
9566020, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | System and method for assessing, measuring, and correcting an anterior-posterior bone cut |
9572512, | Dec 01 2009 | ZOLL MEDICAL ISRAEL LTD | Methods and systems for determining fluid content of tissue |
9615887, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | Bone cutting system for the leg and method therefor |
9622701, | Feb 27 2012 | HOWMEDICA OSTEONICS CORP | Muscular-skeletal joint stability detection and method therefor |
9642676, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | System and method for measuring slope or tilt of a bone cut on the muscular-skeletal system |
9757051, | Nov 09 2012 | HOWMEDICA OSTEONICS CORP | Muscular-skeletal tracking system and method |
9788752, | Jul 21 2010 | ZOLL MEDICAL ISRAEL LTD | Implantable dielectrometer |
9820678, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | Kinetic assessment and alignment of the muscular-skeletal system and method therefor |
9839374, | Sep 23 2011 | HOWMEDICA OSTEONICS CORP | System and method for vertebral load and location sensing |
9839390, | Jun 30 2009 | HOWMEDICA OSTEONICS CORP | Prosthetic component having a compliant surface |
9844335, | Feb 27 2012 | HOWMEDICA OSTEONICS CORP | Measurement device for the muscular-skeletal system having load distribution plates |
9936898, | Mar 18 2013 | HOWMEDICA OSTEONICS CORP | Reference position tool for the muscular-skeletal system and method therefor |
9937062, | Sep 23 2011 | Orthosensor Inc | Device and method for enabling an orthopedic tool for parameter measurement |
Patent | Priority | Assignee | Title |
4240445, | Oct 23 1978 | UNIVERSITY OF UTAH RESEARCH FONDATION, FOUNDATION | Electromagnetic energy coupler/receiver apparatus and method |
4488559, | Jun 30 1981 | University of Utah | Apparatus and method for measuring lung water content |
4647281, | Feb 20 1985 | MICROWAVE MEDICAL SYSTEMS, INC | Infiltration detection apparatus |
4690149, | Oct 28 1985 | The Johns Hopkins University | Non-invasive electromagnetic technique for monitoring physiological changes in the brain |
4877034, | Jun 18 1987 | SMITH & NEPHEW SIGMA, INC | Method and device for detection of tissue infiltration |
5184620, | Dec 26 1991 | Marquette Electronics, Inc. | Method of using a multiple electrode pad assembly |
5334141, | Jun 26 1992 | Medrad, Inc. | Extravasation detection system and apparatus |
5947910, | Jan 14 1994 | ACIST MEDICAL SYSTEMS, INC | Extravasation detection technique |
5954668, | Jun 14 1996 | Medrad, Inc.; MEDRAD, INC | Extravasation detector using microwave radiometry |
5964703, | Jan 14 1994 | ACIST MEDICAL SYSTEMS, INC | Extravasation detection electrode patch |
5995863, | Dec 27 1996 | FONDAZIONE BRUNO KESSLER | Method and an automatic system for obtaining water content and electric-permittivity maps from magnetic resonance images |
6026173, | Jul 05 1997 | EMTensor GmbH | Electromagnetic imaging and therapeutic (EMIT) systems |
6047215, | Mar 06 1998 | SONIQUE SURGICAL SYSTEMS, INC | Method and apparatus for electromagnetically assisted liposuction |
6061589, | Jul 01 1994 | Interstitial, LLC | Microwave antenna for cancer detection system |
6233479, | Sep 15 1998 | Lawrence Livermore National Security LLC | Microwave hematoma detector |
6263226, | Feb 09 1998 | Axelgaard Manufacturing Co., Ltd.; AXELGAARD MANUFACTURING COMPANY, LTD | Sponge electrode |
6300906, | Jan 05 2000 | Virginia Polytechnic Institute and State University; Virginia Tech Intellectual Properties, Inc | Wideband phased array antenna employing increased packaging density laminate structure containing feed network, balun and power divider circuitry |
6332087, | Jul 05 1996 | EMTensor GmbH | Electromagnetic imaging and therapeutic (EMIT) systems |
6408204, | Jul 28 1999 | Bayer HealthCare LLC | Apparatuses and methods for extravasation detection |
6415170, | Dec 09 1996 | 3M Innovative Properties Comany | Biomedical electrode and method for its manufacture |
6487428, | Aug 31 2000 | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE | Extravasation detection apparatus and method based on optical sensing |
7122012, | Jul 26 2001 | Bayer HealthCare LLC | Detection of fluids in tissue |
20030004433, | |||
20030036674, | |||
20030036713, | |||
WO3009753, | |||
WO3063680, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Oct 25 2004 | Medrad, Inc. | (assignment on the face of the patent) | / | |||
Apr 11 2006 | HARPHAM, R READE | BATTELLE MEMORIAL | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 017836 | /0338 | |
Apr 11 2006 | HELD, JEFFREY R | BATTELLE MEMORIAL | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 017836 | /0338 | |
Apr 12 2006 | BATTELLE MEMORIAL | MEDRAD, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 017831 | /0880 | |
Apr 12 2006 | BOUTON, CHAD E | BATTELLE MEMORIAL | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 017836 | /0338 | |
Apr 12 2006 | RUGGERI, FELICIA R | BATTELLE MEMORIAL | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 017836 | /0338 | |
Nov 07 2013 | MEDRAD, INC | Bayer Medical Care Inc | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 032250 | /0165 | |
Oct 19 2015 | BAYER MEDICAL CARE, INC | Bayer HealthCare LLC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 036965 | /0244 |
Date | Maintenance Fee Events |
Apr 06 2016 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Apr 14 2020 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Apr 10 2024 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Oct 23 2015 | 4 years fee payment window open |
Apr 23 2016 | 6 months grace period start (w surcharge) |
Oct 23 2016 | patent expiry (for year 4) |
Oct 23 2018 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 23 2019 | 8 years fee payment window open |
Apr 23 2020 | 6 months grace period start (w surcharge) |
Oct 23 2020 | patent expiry (for year 8) |
Oct 23 2022 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 23 2023 | 12 years fee payment window open |
Apr 23 2024 | 6 months grace period start (w surcharge) |
Oct 23 2024 | patent expiry (for year 12) |
Oct 23 2026 | 2 years to revive unintentionally abandoned end. (for year 12) |